Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
about
Resting heart rate and risk of metabolic syndrome in adults: a dose-response meta-analysis of observational studies.The controversy regarding contrast echocardiography and how it affects patients with the cardiometabolic syndrome.A novel nonparametric approach for estimating cut-offs in continuous risk indicators with application to diabetes epidemiology.The relation of metabolic syndrome according to five definitions to cardiovascular risk factors--a population-based studyTarget organ damage and incident type 2 diabetes mellitus: the Strong Heart StudyVariations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.Molecular determinants of the cardiometabolic phenotype.Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteriaA comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria.Association of metabolic syndrome with coronary artery calcification.High prevalence of metabolic syndrome features in patients previously treated for nonfunctioning pituitary macroadenomaPartial normalization of components of metabolic syndrome does not influence prevalent echocardiographic abnormalities: the HyperGEN studyCOSEHC global vascular risk management quality improvement program: rationale and design.Metabolic syndrome in peritoneal dialysis patients.Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trialComparison Study of Metabolic Syndrome's Differences and Diagnostic Criteria's Applicability among Xingjiang Uighur, Kazak and Han Population.Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study.Metabolic syndrome: do clinical criteria identify similar individuals among overweight premenopausal women?Evaluation of metabolic syndrome in adults of Talca city, Chile.The role of androgens and estrogens on healthy aging and longevity.Metabolic syndrome and periodontitis in Gullah African Americans with type 2 diabetes mellitus.Lack of reduction of left ventricular mass in treated hypertension: the strong heart study.Diversity of metabolic syndrome criteria in association with cardiovascular diseases--a family medicine-based investigationThe COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report.A cross-sectional study of intima-media thickness, ethnicity, metabolic syndrome, and cardiovascular risk in 2268 study participants.Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart studyMetabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study.Is there any relationship between different phenotypes of metabolic syndrome and cardiovascular mortality rate?Cardiovascular Risk Stratification in Patients with Metabolic Syndrome Without Diabetes or Cardiovascular Disease: Usefulness of Metabolic Syndrome Severity Score.Metabolic syndrome and myocardial contractile reserve.Skin to calyx distance is not a predictive factor for miniaturized percutaneous nephrolithotomy outcomes.Incidence of metabolic syndrome and related diseases in the Khisêdjê indigenous people of the Xingu, Central Brazil, from 1999-2000 to 2010-2011.Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients.Does metabolic syndrome worsen systolic dysfunction in diabetes? The shortwave study.Effects of canrenone in patients with metabolic syndrome.Detection of early left ventricular and atrial dysfunction in overweight patients with preserved ejection fraction: a speckle tracking analysis.The Association of Arsenic Exposure and Arsenic Metabolism with the Metabolic Syndrome and its Individual Components: Prospective Evidence from the Strong Heart Family Study.Comparison of miniaturized percutaneous nephrolithotomy and flexible ureterorenoscopy for the management of 10-20 mm renal stones in obese patients.The New Unified International Diabetes Federation/American Heart Association/National Heart, Lung, and Blood Institute Metabolic Syndrome definition: does it correlate better with C-reactive protein in Chinese patients diagnosed with type 2 diabetesComparison of Mask Oxygen Therapy and High-Flow Oxygen Therapy after Cardiopulmonary Bypass in Obese Patients.
P2860
Q30240703-330F10D3-E683-4AE6-852F-B4DF29934B16Q30447962-87825F21-1585-4C81-A3D0-6FA274519AF7Q33501858-D1AB49E6-112E-4A1A-9258-77C0BD69D9D3Q33520385-6804734D-111C-4FB0-BE4E-8AFDB1E47214Q33668181-00AED427-99E0-4811-99DC-D601924A02D9Q33738575-D9B2EA97-1EB0-4B81-AB10-BE1D679CE8F7Q33921392-C04332E4-9934-40EB-A6DA-16FE086F6955Q34611074-BEF3E709-FD50-4578-B7DB-4DA251CC125BQ34635460-E86D3365-F93A-4AA5-8EC3-EC6F2513A260Q34948104-3E88D569-2A31-44A1-B8E6-F0FFBF7EDD99Q35114788-77B62337-28B1-4F9D-B772-D81493CB812CQ35171258-9587668F-28CF-41FE-96CC-05F3ED7472D9Q35204388-FB899B24-DA7F-4DDA-87FC-A861A2BF5812Q35573741-289794A4-DE3F-4713-BDB9-A0B56A9DBCBEQ35777145-28690479-9EE7-463B-8C19-EB1FDDCA72E3Q36241377-377D2071-7849-4B73-9DEE-591FDFED2AABQ36473611-D42825FE-36BA-4D15-A3EC-D1C5D54E0CE7Q36477959-E8BCCF99-48D2-4044-B7F5-37F5F07CEC6BQ36678409-51C977EF-8752-467F-A599-FBDC939EE42DQ36796228-0D365BEA-0497-4BD6-85AA-6670284277E5Q36876043-00735503-533D-4651-A324-389B40C022E6Q36974291-9F22DFB7-6F1E-4E48-8284-9625B7D547A5Q37020686-CFD23761-4777-4D91-AB31-B2281654714DQ37048557-FD75B673-3855-40EA-BB33-FDBC016477E7Q37148410-A5E20F7B-B970-4E38-957B-BC60C7DE1D20Q37245231-D5F8F3A7-1089-4EB3-8544-FE0EFD9BA6FBQ37311398-A8CEBCF0-E99E-42B0-A60E-2D6A3D159541Q37504631-BEF49BA6-B26D-42C2-AFFE-D923B9251412Q40202317-BEE688A8-0F74-4061-9809-BFEC235E7F19Q40443121-83181392-2ADF-4A5B-B617-58714B36E4C4Q41412148-77BD5B4A-44E5-41F7-8E51-094CEF8A16DEQ41706391-D55CDF4F-7860-429C-BD8A-18825A04C10BQ43216549-ED73C53A-E1DE-419B-A4BF-20338CB2D66AQ45378268-F632EDD5-9EDD-486E-8DDA-A7FE3056992FQ47681681-18DB401F-99A2-4439-A669-E6F632AE6C19Q48741299-112E7536-596F-4244-9D49-EFED6CE71EDBQ51244944-5FE7873C-C691-4FAE-A3E9-106C2E7F7E19Q51602483-77C0B316-3B48-4073-8B4E-07E4B262ED0AQ51733325-A3B45931-6110-460D-823A-5AFD58218CA8Q55252349-6A41C367-967D-4CB2-B428-F4104091AD2E
P2860
Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Prognostic impact of metabolic ...... betes: the Strong Heart Study.
@en
Prognostic impact of metabolic ...... betes: the Strong Heart Study.
@nl
type
label
Prognostic impact of metabolic ...... betes: the Strong Heart Study.
@en
Prognostic impact of metabolic ...... betes: the Strong Heart Study.
@nl
prefLabel
Prognostic impact of metabolic ...... betes: the Strong Heart Study.
@en
Prognostic impact of metabolic ...... betes: the Strong Heart Study.
@nl
P2093
P50
P356
P1433
P1476
Prognostic impact of metabolic ...... betes: the Strong Heart Study.
@en
P2093
Helaine E Resnick
James M Galloway
Strong Heart Study Investigators
P304
P356
10.2337/DC06-2152
P407
P577
2007-04-17T00:00:00Z